BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 9169718)

  • 21. Prolonged disease-free survival after autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma with a poor prognosis.
    Takvorian T; Canellos GP; Ritz J; Freedman AS; Anderson KC; Mauch P; Tarbell N; Coral F; Daley H; Yeap B
    N Engl J Med; 1987 Jun; 316(24):1499-505. PubMed ID: 3295542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Busulfan, cyclophosphamide and etoposide as high-dose conditioning therapy in patients with malignant lymphoma and prior dose-limiting radiation therapy.
    Kröger N; Hoffknecht M; Hänel M; Krüger W; Zeller W; Stockschläder M; de Wit M; Weh HJ; Kabisch H; Erttmann R; Zander AR
    Bone Marrow Transplant; 1998 Jun; 21(12):1171-5. PubMed ID: 9674847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The treatment of relapsed or refractory intermediate grade non-Hodgkin's lymphoma with autologous bone marrow transplantation followed by cyclosporine and interferon.
    Gryn J; Johnson E; Goldman N; Devereux L; Grana G; Hageboutros A; Fernandez E; Constantinou C; Harrer W; Viner E; Goldberg J
    Bone Marrow Transplant; 1997 Feb; 19(3):221-6. PubMed ID: 9028549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of relapsed and refractory Hodgkin's disease with high dose chemotherapy and autologous bone marrow transplantation.
    Brice P; Gisselbrecht C; Ferme C; Lepage E; Baruchel A; Marolleau JP; Gerota O; Boiron M
    Nouv Rev Fr Hematol (1978); 1991; 33(3):267-72. PubMed ID: 1956765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-dose therapy with peripheral blood progenitor cell transplantation in low-grade non-Hodgkin's lymphoma.
    Haas R; Moos M; Möhle R; Döhner H; Witt B; Goldschmidt H; Murea S; Flentje M; Wannenmacher M; Hunstein W
    Bone Marrow Transplant; 1996 Feb; 17(2):149-55. PubMed ID: 8640159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Total body irradiation compared with BEAM: Long-term outcomes of peripheral blood autologous stem cell transplantation for non-Hodgkin's lymphoma.
    Liu HW; Seftel MD; Rubinger M; Szwajcer D; Demers A; Nugent Z; Schroeder G; Butler JB; Cooke A
    Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):513-20. PubMed ID: 20137862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autologous peripheral blood stem cell transplantation after high dose therapy in patients with advanced lymphomas.
    Brice P; Marolleau JP; Dombret H; Lepage E; Baruchel A; Adam M; Miclea JM; Sitthy X; Gisselbrecht C
    Bone Marrow Transplant; 1992 May; 9(5):337-42. PubMed ID: 1352162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allogeneic bone marrow transplantation for poor-prognosis lymphoma: response, toxicity and survival depend on disease histology.
    van Besien KW; Mehra RC; Giralt SA; Kantarjian HM; Pugh WC; Khouri IF; Moon Y; Williams P; Andersson BS; Przepiorka D; McCarthy PL; Gajewski JL; Deisseroth AB; Cabanillas FF; Champlin R
    Am J Med; 1996 Mar; 100(3):299-307. PubMed ID: 8629675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The therapeutic and biological effects of total lymph node irradiation and autologous bone marrow infusion on malignant lymphoma patients.
    Yu S; Chen Z; Chen Y; Jiang C; Guo T; Jiang B; Gao P; Kong X
    Chin Med Sci J; 1991 Dec; 6(4):197-202. PubMed ID: 1813057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-dose therapy and autologous bone marrow transplantation for Hodgkin's disease patients with relapses potentially treatable by radical radiation therapy.
    Pezner RD; Nademanee A; Forman SJ
    Int J Radiat Oncol Biol Phys; 1995 Aug; 33(1):189-94. PubMed ID: 7642418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase I study of escalating doses of low-dose-rate, locoregional irradiation preceding Cytoxan-TBI for patients with chemotherapy-resistant non-Hodgkin's or Hodgkin's lymphoma.
    Song DY; Jones RJ; Welsh JS; Haulk TL; Korman LT; Noga S; Goodman S; Herman M; Mann R; Marcellus D; Vogelsang G; Ambinder RF; Abrams RA
    Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):166-71. PubMed ID: 12909229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-Hodgkin lymphoma: whole-abdomen irradiation as an adjuvant to chemotherapy.
    Valicenti RK; Wasserman TH; Monyak DJ; Kucik NA
    Radiology; 1994 Aug; 192(2):571-6. PubMed ID: 8029434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new technique for the irradiation of large fields in patients with lymphoma.
    Nisce LZ; D'Angio GJ
    Radiology; 1973 Mar; 106(3):641-4. PubMed ID: 4567835
    [No Abstract]   [Full Text] [Related]  

  • 34. Modern radiotherapeutic strategies in the management of lymphoma.
    Ballas L
    Future Oncol; 2015; 11(6):1011-20. PubMed ID: 25760980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary non-Hodgkin lymphoma of the small bowel.
    Ha CS; Cho MJ; Allen PK; Fuller LM; Cabanillas F; Cox JD
    Radiology; 1999 Apr; 211(1):183-7. PubMed ID: 10189469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-dose total body irradiation in non-Hodgkin lymphoma: short- and long-term toxicity and prognostic factor.
    De Neve WJ; Lybeert ML; Meerwaldt JH
    Am J Clin Oncol; 1990 Aug; 13(4):280-4. PubMed ID: 2198791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short-term radiation therapy of localized lymphoma.
    Fridman M; Stutzman L; Vongtama V; Panahon A; Ezdinli E; Webster JH
    Radiology; 1972 Feb; 102(2):413-6. PubMed ID: 4550637
    [No Abstract]   [Full Text] [Related]  

  • 38. Use of retroviral markers to identify efficacy of purging and origin of relapse following autologous bone marrow and peripheral blood cell transplantation in indolent B cell neoplasms (follicular non-Hodgkin's lymphoma or chronic lymphocytic leukemia (CLL) patients).
    Hum Gene Ther; 1993 Dec; 4(6):821-34. PubMed ID: 8186294
    [No Abstract]   [Full Text] [Related]  

  • 39. Involved-field irradiation in combination with total-body irradiation (TBI) does not increase short-term toxicity compared to TBI alone in patients with advanced-stage low-grade non-Hodgkin lymphoma.
    Ott M; Schmidberger H; Wörmann B; Albrecht CF; Pradier O; Hess CF
    Strahlenther Onkol; 2002 May; 178(5):245-51. PubMed ID: 12082683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Radiation therapy for malignant lymphoma].
    Asakawa I; Tamamoto T; Hasegawa M
    Nihon Rinsho; 2014 Mar; 72(3):468-72. PubMed ID: 24724405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.